Divi’s Laboratories Ltd. (DIVISLAB): Divi’s Laboratories Share Price Rises 2.35% Today
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
Divi’s Laboratories Share Price moved higher today, with the stock closing at Rs 9,563.20 after rising 2.35% from the previous close of Rs 9,344. The company’s market capitalisation stood at Rs 2,50,389.96 crore, placing the day’s move in the context of a large listed healthcare company within the pharmaceuticals and drugs industry. The data confirms a same-day price rise, but it does not establish a company-specific catalyst, so the focus remains on the verified market numbers and the business backdrop. Divi’s Laboratories Share Price Today is therefore being tracked as both a price action event and a valuation check. For readers following Divi’s Laboratories Stock News, the important questions are what the move says about today’s trade and how the current price compares with sector and peer benchmarks. Univest is covering the event with the same factual lens used across market updates.
Divi’s Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 9,563.2 |
| Previous Close | Rs 9,344 |
| Today's Move | Rs 219.2 (+2.35%) |
| Open | Rs 9,305.95 |
| High | Rs 9,565 |
| Low | Rs 9,305.95 |
| Turnover | Rs 7.49 crore |
| Market Capitalisation | Rs 2,50,389.96 crore |
| Market Cap Category | Large Cap |
Divi's Laboratories Ltd. (DIVISLAB) rose to Rs 9,563.2 from the previous close of Rs 9,344, a move of Rs 219.2 or 2.35%. The stock opened at Rs 9,305.95, reached a high of Rs 9,565, recorded a low of Rs 9,305.95.
Divi’s Laboratories Share Price opened at Rs 9,305.95, matched the day’s low at the same level, and reached a high of Rs 9,565 before settling at Rs 9,563.20. That left the stock Rs 219.20 above the previous close, a gain of 2.35% for the session. The movement shows a clear same-day share price rise, with the closing level near the intraday high. The reported turnover of Rs 7.49 crore provides a factual trade-value reference for the session. Divi’s Laboratories Share Price Today is also notable because the current price sits above the day’s opening level and near the high, which is the central point for anyone reading Divi’s Laboratories Stock News or checking Divi’s Laboratories Share Price Live on Univest.
Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,50,389.96 crore |
| P/E Ratio | 84.8x |
| P/B Ratio | 14.04x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.32% |
Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 84.8x, P/B 14.04x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.
Divi’s Laboratories Ltd. has a market capitalisation of Rs 250389.96 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.8x, P/B at 14.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.32%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.75x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 84.8x |
| Benchmark Median P/E | 31.75x |
| Benchmark Average P/E | 49.54x |
| Benchmark P/E Range | 3.48x to 765.12x |
| Company P/B Ratio | 14.04x |
| Benchmark Median P/B | 3x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 2,50,389.96 crore |
| Benchmark Median Market Cap | Rs 748.47 crore |
Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 84.8x, which is above the benchmark median of 31.75x, a difference of +167.09%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.7%, a difference of +38.38%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.46%, a difference of +59.81%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,195.77 | 36.58 | 5.12 | 14.85 | 19.11 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,966.75 | 87.04 | 21.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,860.07 | 25.66 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.1 | 3.17 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,09,035.01 | 99.09 | 19.21 | 18.31 | 18.2 |
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 84.8x compared with the displayed peer median of 36.58x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,50,389.96 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Divi’s Laboratories
- Divi’s Laboratories Share Price rose 2.35% today to Rs 9,563.20, after closing above the previous close of Rs 9,344.
- The company’s market capitalisation stood at Rs 2,50,389.96 crore, which places it well above the benchmark median in its industry.
- P/E of 84.8 and P/B of 14.04 show a valuation level above the broader healthcare comparison set.
- ROE of 16.19% and ROCE of 21.51% are both above the industry median and average in the supplied benchmark data.
- EPS of Rs 110.18, book value of Rs 665.36 and dividend yield of 0.32% add further context to Divi’s Laboratories Fundamental Analysis.
About Divi’s Laboratories Ltd.
Divi’s Laboratories Ltd. operates in the pharmaceuticals and drugs industry within the healthcare sector. The company is followed for its market position, business scale and financial profile, all of which are reflected in the supplied market data. Investors tracking Divi’s Laboratories Share Price often look at the company alongside Divi’s Laboratories Company News, Divi’s Laboratories Earnings and Divi’s Laboratories Financial Results because the stock tends to be discussed in the context of valuation and profitability rather than only one day’s move. The current market capitalisation of Rs 2,50,389.96 crore shows the scale of the listed business, while the P/E, P/B, ROE, ROCE, EPS, book value and dividend yield provide the main fundamental reference points. In Univest’s coverage, the company is best understood through its verified financial metrics, its industry classification and its comparison with other listed pharmaceutical names. That makes Divi’s Laboratories Share Price Today relevant both as a market event and as a company-specific stock update.
Track Divi’s Laboratories Share Price on Univest
Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Divi’s Laboratories Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. The same page also helps users follow Divi’s Laboratories Share Price Today alongside company news, peer comparison and stock performance context. If you are checking Divi’s Laboratories Stock News, Univest keeps the numbers organised so you can review the market data, the valuation profile and the broader healthcare sector view without guesswork. That is the practical use case for Divi’s Laboratories Share Price Update and Divi’s Laboratories Latest News coverage on the platform.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Divi's Laboratories Share Price rise today?
Ans. The verified data confirms a same-day price rise, but it does not establish a company-specific catalyst. Divi's Laboratories Share Price moved from Rs 9,344 to Rs 9,563.20, which is a 2.35% gain.
What is Divi's Laboratories Share Price Today?
Ans. Divi's Laboratories Share Price Today is Rs 9,563.20. The stock gained Rs 219.20 during the session and finished near the day’s high, after opening at Rs 9,305.95. The previous close was Rs 9,344.
What is the market capitalisation of Divi's Laboratories?
Ans. Divi's Laboratories has a market capitalisation of Rs 2,50,389.96 crore. That figure places it far above the benchmark median and average in the supplied pharmaceuticals and drugs industry comparison. The company operates in the Healthcare sector.
How does Divi's Laboratories look on valuation?
Ans. Divi's Laboratories trades at a P/E of 84.8 and a P/B of 14.04. Both are above the sector median and average, so the stock is positioned at a premium versus the supplied benchmark set.
What do Divi's Laboratories profitability metrics show?
Ans. Divi's Laboratories reports ROE of 16.19% and ROCE of 21.51%. Both are above the industry median and average, which gives useful context when reviewing Divi's Laboratories Share Price and financial quality.
How does Divi's Laboratories compare with peers?
Ans. Divi's Laboratories has a higher P/E than Sun Pharma, Cipla, Zydus, Dr. Reddy’s and Aurobindo, while its ROE and ROCE are also stronger than several of those peers in the supplied set.
How can investors track Divi's Laboratories Share Price on Univest?
Ans. Univest lets users follow Divi's Laboratories Share Price, financial ratios, shareholding pattern, 52-week levels and market insights together. It is a practical way to review Divi's Laboratories Stock News and price updates in one place.
